TransMedics (TMDX) Invested Capital (2025 - 2026)

TransMedics' (TMDX) quarterly Invested Capital came in at $15.0 million in Q1 2026, up 50.0% quarter-over-quarter from $10.0 million in Q4 2025.

TransMedics (TMDX) Invested Capital (2025 - 2026) Analysis & Trends

TransMedics' Invested Capital history runs 2 years deep, the most recent figure standing at $15.0 million for Q1 2026.

On a quarterly basis, Invested Capital changed N/A year-over-year to $15.0 million in Q1 2026; TTM through Mar 2026 was $30.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $10.0 million, changed N/A from the prior year.
Invested Capital grew to $15.0 million in Q1 2026 per TMDX's latest filing, from $10.0 million in the prior quarter.
Across five years, Invested Capital topped out at $15.0 million in Q1 2026 and bottomed at $5.0 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	184.21 Bn	176.92 Bn	6.27 Bn	4.41 Bn
2	Stryker	128.90 Bn	126.02 Bn	3.81 Bn	499.00 Mn
3	Medtronic	109.00 Bn	99.78 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	68.62 Bn	67.16 Bn	3.61 Bn	41.00 Mn
5	Edwards Lifesciences	47.39 Bn	43.72 Bn	1.29 Bn	-
6	GE HealthCare Technologies	28.44 Bn	26.16 Bn	1.98 Bn	7.00 Mn
7	Dexcom	28.39 Bn	27.27 Bn	750.30 Mn	-
8	Smith & Nephew	27.03 Bn	26.46 Bn	-	15.00 Mn
9	Koninklijke Philips	25.55 Bn	22.43 Bn	2.07 Bn	1.41 Bn
10	TransMedics	2.51 Bn	2.05 Bn	101.16 Mn	15.00 Mn

Download Data